ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Sen. Pryor Attacks Drug Industry, NIH Technology Transfer

March 5, 1993

Regions Outlined In CIS Proposal

May 31, 1991

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014

Arbuck Leaves NCI to Guide BMS Oncology Pipeline.

September 7, 2001

In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.”

July 29, 2005

Techniclone Wins Patent For Tumor Necrosis Therapy.

February 25, 2000